Nipro Corporation Medical Device Company Intelligence Report

Table of Contents

EXECUTIVE SUMMARY

• OVERVIEW
  • Recent Key Events
• Fiscal 2005
  • Revenue by Business, Y/E 31 March 2003-2006 (¥ million)*
  • Fig.1: Percentage of Revenue by Operating Division, Y/E 31st March 2006*
  • Fig.2: Percentage of Operating Income by Division, Y/E 31st March 2006*
• Latest Results
• STRATEGIC FOCUS
  • Medical Division

PRODUCT PORTFOLIO AND R&D

• MEDICAL DIVISION PRODUCTS
  • Medical Division - Operating Results Y/E 31 March 2003-2006 (¥ million)*
  • Fig.3: Medical Division Revenue, Y/E 31st March 1999-2006 (¥ billion)*
  • Fig.4: Medical Revenue by Product, Y/E 31st March 2006 (¥ billion)*
• Artificial Organs
  • Dialysis
    • Fig.5: Dialysis Market Shares, 2005*
      • Dialysis Machines
      • Dialysers
      • Dialysis Accessories
  • Insulin Pump Therapy
    • Fig.6: Global Insulin Infusion Market, 2005*
      • Amigo Insulin Pump
• Injection and Infusion-Related Devices
  • Fig.7: Projected Market - Needles, Syringes & Catheters, 2005-2010 (US$ million)*
• Needles and Syringes
• Catheters and Catheter Access Products
  • PTCA Catheters
  • IV Catheters
  • Infusion Pumps
  • Infusion Management System
  • Winged Infusion Sets
  • PVC-Free Non-Drug-Absorbent Infusion Set
  • Enteral Alimentation System
  • Vacuum Blood Collection Tube
  • SafeTouch Safety Scalp Vein and Blood Collection Sets
  • SafeTouch PSV Set
  • Angiography Guidewires
• Other Products
  • Blood Glucose Monitoring
    • Fig.8: Global Blood Glucose Monitoring Market, 2005*
      • Freestyle Blood Glucose Monitoring System
      • Nipro FreeStyle Meter Freedom
      • FreeStyle Flash
  • Tento-Mushi
  • Cocoro Meter
  • PulseCO Monitor
• PHARMACEUTICAL DIVISION PRODUCTS
• Pharmaceutical Division - Operating Results Y/E 31st March 2003-2006 (¥ million)*
  • Pre-filled Syringes
  • Double Bag Kits
  • Full Kit
  • Half Kit
• RESEARCH AND DEVELOPMENT
• Research Establishments
• Research Projects
• Regenerative Medicine
  • Pericardium Regeneration Material
  • Nerve Regeneration Tubes
  • Artificial Oxygen Carriers
• Artificial Organs
  • Vascular Prostheses
  • Dialysis Products
• Drug Delivery Systems
• Research Agreements
  • Oxygenix and Japanese Universities
  • Thoratec
  • Bipha Corporation

INTERNATIONAL ACTIVITIES

• Sales Analysis
  • Revenue by Location of Company, Y/E 31st March 2003-2006 (¥ million)*
  • Operating Income by Location of Company, Y/E 31st March 2003-2006 (¥million)*
  • Revenue by Location of Customer, Y/E 31st March 2005-2006 (¥ million)*
  • Fig.9: Revenue by Location of Company, Y/E 31st March 2006*
  • Fig.10: Revenue by Location of Customer, Y/E 31st March 2006*
• JAPAN
• THE AMERICAS
  • Brazil
• EUROPE
• ASIA-PACIFIC
  • China
  • Thailand
    • Global Manufacturing Facilities

APPENDICES

• APPENDIX 1 - FINANCIAL INDICATORS
• APPENDIX 2 - KEY CORPORATE EVENTS
• APPENDIX 3 - MERGERS AND ACQUISITIONS
  • Edwards Lifesciences' Perfusion Assets
  • Dainippon Ink and Chemicals' Oxygenator Business
  • Hishiyama Pharmaceutical Co. Ltd
• APPENDIX 4 - JOINT VENTURES
  • US Insulin Pump Company
• APPENDIX 5 - MINORITY INVESTMENTS
  • Bipha Corporation
• APPENDIX 6 - DIVESTITURES
  • Nissho Corporation
• APPENDIX 7 - AGREEMENTS
  • AngioDynamics
  • Rockwell Medical Technologies
  • Abbott (TheraSense) and Kissei Pharmaceutical
  • LiDCO
  • Hy-Med Health
  • Biorena
  • GE Osmonics
  • Membrana
  • Gambro

INDEX OF TABLES

• Recent Key Events
• Revenue by Business, Y/E 31 March 2003-2006 (¥ million)*
• Medical Division - Operating Results Y/E 31 March 2003-2006 (¥ million)*
• Pharmaceutical Division - Operating Results Y/E 31st March 2003-2006 (¥ million)*
• Revenue by Location of Company, Y/E 31st March 2003-2006 (¥ million)*
• Operating Income by Location of Company, Y/E 31st March 2003-2006 (¥ million)*
• Revenue by Location of Customer, Y/E 31st March 2005-2006 (¥ million)*
• Global Manufacturing Facilities

INDEX OF CHARTS

• Fig.1: Percentage of Revenue by Operating Division, Y/E 31st March 2006*
• Fig.2: Percentage of Operating Income by Division, Y/E 31st March 2006*
• Fig.3: Medical Division Revenue, Y/E 31st March 1999-2006 (¥ billion)*
• Fig.4: Medical Revenue by Product, Y/E 31st March 2006 (¥ billion)*
• Fig.5: Dialysis Market Shares, 2005*
• Fig.6: Global Insulin Infusion Market, 2005*
• Fig.7: Projected Market - Needles, Syringes & Catheters, 2005-2010 (US$ million)*
• Fig.8: Global Blood Glucose Monitoring Market, 2005*
• Fig.9: Revenue by Location of Company, Y/E 31st March 2006*
• Fig.10: Revenue by Location of Customer, Y/E 31st March 2006*